Shine working toward U.S. production of Mo-99 for SPECT nuclear imaging

 Greg Piefer, PhD, CEO and founder of Shine, explains the timeline to restart U.S. production of molybdenum-99 (Mo-99) for nuclear imaging.

Greg Piefer, PhD, chief executive and founder of Shine, a Wisconsin-based radiopharmaceutical company that is building the world’s largest medical isotope production facility in Janesville, Wisconsin, explains progress on the company's fusion reactor that will become the first sustained U.S. commercial supplier of molybdenum-99 in decades.